Complete Filing Data
Bioventus Inc. reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents of $51.24 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Bioventus Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | $22.7M | -$36.1M | -$156.2M | -$158.7M | $19.4M | $16.4M | $6.9M |
| Selling General And Administrative Expense | $314.0M | $343.8M | $303.9M | $332.1M | $254.3M | $193.1M | $198.5M |
| Revenue From Contract With Customer Excluding Assessed Tax | $568.1M | $573.3M | $512.3M | $512.1M | $430.9M | $321.2M | $340.1M |
| Research And Development Expense | $12.1M | $14.0M | $13.4M | $23.9M | $19.0M | $11.2M | $11.1M |
| Other Nonoperating Income Expense | -$1.5M | $1.6M | $1.3M | -$9.8M | -$1.5M | $4.4M | $75.0K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $1.8M | -$4.2M | $1.1M | -$501.0K | -$1.3M | $2.1M | -$322.0K |
| Operating Income Loss | $54.0M | -$15.2M | -$81.7M | -$167.2M | $12.1M | $21.2M | $31.2M |
| Interest Income Expense Nonoperating Net | -$26.5M | -$38.8M | -$40.7M | -$12.0M | -$1.1M | -$9.8M | -$21.6M |
| Income Tax Expense Benefit | -$1.6M | -$5.3M | $85.0K | -$44.4M | -$2.0M | $1.2M | $1.6M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $25.7M | -$52.3M | -$121.1M | -$189.0M | $9.5M | $15.9M | $9.7M |
| Gross Profit | $388.2M | $388.2M | $328.2M | $331.1M | $302.7M | $233.5M | $249.2M |
| Cost Of Goods And Services Sold Depreciation And Amortization | $41.3M | $41.9M | $48.5M | $45.6M | $26.5M | $21.2M | $22.4M |
| Cost Of Goods And Services Sold | $179.9M | $185.1M | $184.2M | $181.0M | $128.2M | $87.6M | $90.9M |
| Comprehensive Income Net Of Tax | $23.4M | -$39.5M | -$155.3M | -$159.0M | $18.1M | $18.5M | $6.5M |
| Nonoperating Income Expense | -$28.3M | -$37.1M | -$39.4M | -$21.8M | -$2.6M | -$5.3M | -$21.5M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $28.1M | -$51.2M | -$194.5M | -$213.8M | $8.3M | $16.8M | $5.9M |
| Asset Impairment Charges | $0.00 | $36.4M | $78.6M | $135.0M | $7.0M | $0.00 | $0.00 |
| Restructuring Charges | $2.2M | -$52.0K | $840.0K | $6.8M | $2.5M | $563.0K | $575.0K |
| Deferred Income Tax Liabilities Net | $433.0K | $564.0K | $1.2M | $2.2M | $59.7M | $3.4M | |
| Net Income Loss Attributable To Noncontrolling Interest | -$54.7M | -$9.8M | -$1.7M | -$553.0K | |||
| Deferred Income Taxes And Tax Credits | -$909.0K | -$5.4M | -$2.4M | -$46.7M | -$9.8M | $644.0K | -$348.0K |
| Income Loss From Continuing Operations Per Diluted Share | $0.33 | -$0.56 | -$1.54 | -$1.70 | -$0.11 | ||
| Income Loss From Continuing Operations Per Basic Share | $0.34 | -$0.56 | -$1.54 | -$1.70 | -$0.11 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $3.2M | $7.5M | -$2.6M | -$5.2M | -$25.7M | -$4.9M | -$7.3M | -$3.7M | -$139.2M | -$108.2M | -$7.3M | -$11.3M | -$1.1M | -$4.1M | $24.9M | $8.5M | -$5.8M | $10.9M |
| Selling General And Administrative Expense | $78.7M | $79.1M | $73.5M | $81.5M | $96.7M | $78.8M | $69.8M | $74.8M | $80.9M | $79.0M | $89.6M | $86.1M | $69.6M | $69.1M | $34.7M | $50.3M | $40.5M | $40.3M |
| Revenue From Contract With Customer Excluding Assessed Tax | $138.7M | $147.7M | $123.9M | $139.0M | $151.2M | $129.5M | $120.8M | $137.1M | $119.1M | $128.7M | $140.3M | $117.3M | $108.9M | $109.8M | $81.8M | $85.9M | $58.0M | $78.6M |
| Research And Development Expense | $2.9M | $3.2M | $3.0M | $3.8M | $4.2M | $2.6M | $3.0M | $3.4M | $3.8M | $4.6M | $6.4M | $6.9M | $6.2M | $4.8M | $947.0K | $3.6M | $2.6M | $2.1M |
| Other Nonoperating Income Expense | -$79.0K | -$561.0K | -$777.0K | $626.0K | -$159.0K | -$63.0K | -$494.0K | -$513.0K | $1.6M | -$115.0K | -$604.0K | $363.0K | -$757.0K | -$1.6M | -$419.0K | $3.3M | $1.3M | -$2.5M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$528.0K | $1.6M | $633.0K | $575.0K | -$426.0K | -$585.0K | -$324.0K | $303.0K | $657.0K | -$723.0K | -$507.0K | -$682.0K | -$366.0K | $23.0K | -$1.2M | $943.0K | $213.0K | -$469.0K |
| Operating Income Loss | $11.3M | $18.4M | $4.9M | $3.6M | -$31.5M | $4.9M | $2.4M | $6.8M | -$92.1M | -$126.8M | -$3.3M | -$21.5M | -$1.0M | -$5.7M | $22.0M | $6.9M | -$4.6M | $13.0M |
| Interest Income Expense Nonoperating Net | -$6.2M | -$7.5M | -$7.5M | -$9.5M | -$9.9M | -$10.3M | -$10.1M | -$10.6M | -$9.7M | -$3.6M | -$2.6M | $1.6M | -$1.3M | -$1.7M | $2.9M | -$1.9M | -$2.8M | -$2.4M |
| Income Tax Expense Benefit | $664.0K | $1.0M | -$95.0K | $589.0K | -$7.3M | $907.0K | $600.0K | $381.0K | -$146.0K | -$29.5M | $1.2M | -$5.1M | -$882.0K | $1.7M | -$73.0K | $373.0K | -$110.0K | $39.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $4.7M | $10.3M | -$3.4M | -$5.3M | -$41.6M | -$5.5M | -$8.2M | -$4.4M | -$100.2M | -$130.6M | -$6.5M | -$19.5M | -$3.2M | -$9.1M | $24.5M | $8.3M | -$6.1M | $10.5M |
| Gross Profit | $94.2M | $102.1M | $83.1M | $93.6M | $103.6M | $88.4M | $78.9M | $89.1M | $73.9M | $84.5M | $96.7M | $75.7M | $79.1M | $76.3M | $59.6M | $62.5M | $40.3M | $57.2M |
| Cost Of Goods And Services Sold Depreciation And Amortization | $10.0M | $10.6M | $10.3M | $10.2M | $11.0M | $10.0M | $11.5M | $12.3M | $14.3M | $11.3M | $9.7M | $9.2M | $6.6M | $5.6M | $5.2M | $5.5M | $5.3M | $5.3M |
| Cost Of Goods And Services Sold | $44.4M | $45.6M | $40.8M | $45.4M | $47.6M | $41.1M | $41.9M | $47.9M | $45.1M | $44.1M | $43.7M | $41.6M | $29.8M | $33.5M | $22.2M | $23.4M | $17.7M | $21.4M |
| Comprehensive Income Net Of Tax | $2.1M | $8.7M | -$2.1M | -$4.7M | -$26.0M | -$5.4M | -$7.6M | -$3.4M | -$138.6M | -$64.2M | -$7.4M | -$11.4M | -$1.3M | -$4.1M | $23.8M | $9.4M | -$5.6M | $10.5M |
| Nonoperating Income Expense | -$6.6M | -$8.1M | -$8.3M | -$8.9M | -$10.1M | -$10.4M | -$10.6M | -$11.1M | -$8.1M | -$3.7M | -$3.2M | $1.9M | -$2.1M | -$3.3M | $2.5M | $1.4M | -$1.5M | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $2.7M | $10.9M | -$2.7M | -$5.3M | -$34.6M | -$7.0M | -$9.1M | -$4.4M | -$173.8M | -$101.8M | -$8.2M | -$15.1M | -$2.6M | -$10.8M | $23.4M | $8.9M | -$5.8M | |
| Asset Impairment Charges | $0.00 | $0.00 | $0.00 | $78.6M | $124.7M | $0.00 | $0.00 | $0.00 | $5.7M | $0.00 | $0.00 | |||||||
| Restructuring Charges | $0.00 | $0.00 | $0.00 | -$26.0K | $620.0K | $317.0K | $575.0K | $1.0M | $577.0K | $1.8M | $0.00 | $0.00 | $0.00 | |||||
| Deferred Income Tax Liabilities Net | $786.0K | $651.0K | $607.0K | $0.00 | $0.00 | $1.3M | $0.00 | $0.00 | $351.0K | $159.3M | $98.9M | $116.0M | $47.7M | $48.4M | $49.0M | |||
| Net Income Loss Attributable To Noncontrolling Interest | $851.0K | $1.8M | -$685.0K | -$683.0K | -$8.5M | -$1.5M | -$37.5M | -$762.0K | -$3.5M | -$1.2M | -$6.7M | -$408.0K | -$492.0K | -$214.0K | -$458.0K | |||
| Deferred Income Taxes And Tax Credits | $43.0K | $81.0K | -$2.7M | -$17.0M | $83.0K | |||||||||||||
| Income Loss From Continuing Operations Per Diluted Share | -$0.07 | -$0.37 | -$0.07 | -$0.12 | -$0.06 | -$1.28 | -$1.18 | -$0.11 | -$0.18 | |||||||||
| Income Loss From Continuing Operations Per Basic Share | -$0.07 | -$0.37 | -$0.07 | -$0.12 | -$0.06 | -$1.28 | -$1.18 | -$0.11 | -$0.18 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $184.1M | $147.9M | $173.6M | $325.2M | $458.9M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $51.2M | $41.6M | $37.0M | $31.8M | $99.2M | $86.8M | $64.5M | $42.8M |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | $0.00 | $1.4M | $719.0K | $1.1M | $829.0K | $0.00 | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $9.7M | $4.6M | $5.1M | -$67.4M | $12.4M | $22.3M | $21.7M | |
| Liabilities | $455.1M | $542.4M | $589.8M | $960.4M | $618.2M | $350.3M | ||
| Other Operating Activities Cash Flow Statement | $1.2M | $2.8M | $1.7M | $388.0K | $588.0K | $966.0K | $2.0M | |
| Goodwill | $7.5M | $7.5M | $7.5M | $7.5M | $147.6M | $49.8M | ||
| Prepaid Expense And Other Assets Current | $11.1M | $14.2M | $16.9M | $18.6M | $27.2M | $7.6M | ||
| Other Liabilities Noncurrent | $15.3M | $23.1M | $27.9M | $22.8M | $21.7M | $21.7M | ||
| Other Liabilities Current | $4.2M | $3.9M | $4.8M | $3.6M | $3.6M | $3.9M | ||
| Operating Lease Right Of Use Asset | $5.1M | $6.5M | $13.4M | $16.7M | $17.2M | $15.0M | ||
| Long Term Investments | $2.3M | $1.9M | $3.1M | $2.6M | $29.3M | $19.4M | ||
| Long Term Debt Noncurrent | $279.0M | $308.3M | $367.0M | $385.0M | $339.6M | $173.4M | ||
| Long Term Debt Current | $15.0M | $27.3M | $27.8M | $33.1M | $18.0M | $15.0M | ||
| Liabilities Current | $160.4M | $210.4M | $175.5M | $304.0M | $180.9M | $122.6M | ||
| Liabilities And Stockholders Equity | $683.6M | $728.0M | $810.9M | $1.37B | $1.23B | $494.5M | ||
| Inventory Net | $82.2M | $92.5M | $91.3M | $84.8M | $61.7M | $29.1M | ||
| Intangible Assets Net Excluding Goodwill | $368.4M | $404.7M | $482.4M | $639.9M | $695.2M | $191.7M | ||
| Cash And Cash Equivalents At Carrying Value | $51.2M | $41.6M | $37.0M | $30.2M | $43.9M | $86.8M | ||
| Assets Current | $272.8M | $275.6M | $268.0M | $272.6M | $263.1M | $211.8M | ||
| Assets | $683.6M | $728.0M | $810.9M | $1.37B | $1.23B | $494.5M | ||
| Accrued Liabilities Current | $130.2M | $135.9M | $119.8M | $111.6M | $131.5M | $88.2M | ||
| Accounts Receivable Net Current | $128.3M | $127.4M | $122.8M | $136.3M | $125.0M | $88.3M | ||
| Accounts Payable Current | $10.9M | $23.7M | $23.0M | $36.7M | $16.9M | $4.4M | ||
| Repayments Of Other Long Term Debt | $9.1M | $44.6M | $38.3M | $20.0M | $91.3M | $10.0M | $199.5M | |
| Minority Interest | $44.3M | $37.7M | $47.5M | $87.0M | $140.7M | |||
| Retained Earnings Accumulated Deficit | -$334.9M | -$357.7M | -$321.5M | -$165.3M | -$6.6M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.9M | -$2.6M | $794.0K | -$110.0K | $179.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $166.1M | $161.2M | $148.1M | $148.7M | $150.9M | $171.3M | $177.5M | $183.2M | $188.5M | $343.4M | $448.0M | $449.8M | $152.5M | $141.6M | $142.4M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $42.2M | $32.9M | $22.8M | $43.1M | $32.0M | $25.2M | $26.8M | $29.4M | $47.1M | $34.4M | $41.0M | $82.7M | $130.9M | $138.1M | $129.5M | $72.5M | $126.2M | $130.3M |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | $0.00 | $0.00 | $0.00 | $483.0K | $300.0K | $295.0K | -$98.0K | $240.0K | $287.0K | $278.0K | $273.0K | $269.0K | $651.0K | $641.0K | $0.00 | $0.00 | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$18.8M | -$11.8M | $15.3M | -$16.6M | $42.6M | $65.8M | ||||||||||||
| Liabilities | $494.3M | $505.5M | $505.9M | $582.7M | $603.1M | $576.8M | $584.6M | $603.6M | $647.0M | $1.02B | $688.6M | $675.2M | $424.3M | $427.3M | $422.8M | |||
| Other Operating Activities Cash Flow Statement | $381.0K | $581.0K | $224.0K | $203.0K | $392.0K | |||||||||||||
| Goodwill | $7.5M | $7.5M | $7.5M | $7.5M | $7.5M | $7.5M | $7.5M | $7.5M | $7.5M | $15.4M | $143.2M | $148.0M | $52.9M | $52.1M | $53.5M | |||
| Prepaid Expense And Other Assets Current | $12.1M | $13.5M | $14.4M | $16.9M | $23.6M | $18.2M | $12.2M | $15.3M | $17.2M | $27.6M | $24.1M | $28.8M | $23.2M | $15.9M | $12.0M | |||
| Other Liabilities Noncurrent | $20.5M | $21.3M | $22.0M | $26.1M | $26.9M | $28.3M | $30.9M | $32.0M | $28.6M | $24.3M | $22.5M | $23.0M | $22.6M | $24.2M | $25.1M | |||
| Other Liabilities Current | $4.4M | $4.4M | $4.4M | $3.9M | $3.8M | $4.8M | $4.7M | $4.7M | $4.3M | $3.5M | $3.8M | $3.9M | $3.0M | $4.0M | $10.2M | |||
| Operating Lease Right Of Use Asset | $5.8M | $6.2M | $6.6M | $9.8M | $10.4M | $12.5M | $14.3M | $15.2M | $16.1M | $16.3M | $18.3M | $18.7M | $16.9M | $17.7M | $18.1M | |||
| Long Term Investments | $2.3M | $1.7M | $1.8M | $1.9M | $2.1M | $3.2M | $6.9M | $6.5M | $2.6M | $13.0M | $78.5M | $28.8M | $29.3M | $19.5M | $21.2M | |||
| Long Term Debt Noncurrent | $311.3M | $297.9M | $308.6M | $345.0M | $344.7M | $355.4M | $375.0M | $374.6M | $404.3M | $393.1M | $351.4M | $348.0M | $162.4M | $166.1M | $169.7M | |||
| Long Term Debt Current | $11.3M | $43.4M | $37.3M | $38.6M | $38.6M | $35.8M | $19.6M | $11.3M | $41.3M | $31.3M | $22.5M | $20.3M | $15.0M | $15.0M | $15.0M | |||
| Liabilities Current | $161.8M | $185.7M | $174.8M | $211.5M | $231.5M | $173.3M | $160.8M | $179.1M | $196.1M | $288.4M | $198.9M | $171.5M | $160.7M | $158.2M | $149.0M | |||
| Liabilities And Stockholders Equity | $701.6M | $706.8M | $691.4M | $769.5M | $792.2M | $794.2M | $811.1M | $837.0M | $887.4M | $1.40B | $1.21B | $1.20B | $654.8M | $646.6M | $643.1M | |||
| Inventory Net | $96.3M | $96.5M | $94.0M | $90.0M | $87.6M | $97.0M | $97.6M | $96.3M | $88.0M | $77.0M | $69.1M | $64.7M | $36.6M | $34.0M | $39.8M | |||
| Intangible Assets Net Excluding Goodwill | $377.4M | $387.0M | $395.7M | $414.8M | $424.6M | $470.7M | $493.3M | $505.2M | $516.0M | $1.06B | $666.5M | $681.4M | $248.8M | $257.8M | $271.0M | |||
| Cash And Cash Equivalents At Carrying Value | $42.2M | $32.9M | $22.8M | $43.1M | $32.0M | $25.2M | $26.8M | $29.4M | $47.1M | $34.4M | $41.0M | $27.4M | $80.9M | $136.1M | $124.2M | |||
| Assets Current | $280.9M | $275.2M | $249.4M | $298.7M | $308.9M | $265.9M | $249.5M | $260.6M | $308.7M | $271.1M | $277.2M | $245.4M | $246.1M | $290.1M | $270.7M | |||
| Assets | $701.6M | $706.8M | $691.4M | $769.5M | $792.2M | $794.2M | $811.1M | $837.0M | $887.4M | $1.40B | $1.21B | $1.20B | $654.8M | $646.6M | $643.1M | |||
| Accrued Liabilities Current | $119.4M | $113.7M | $103.3M | $128.7M | $140.0M | $113.6M | $118.9M | $121.7M | $115.8M | $116.9M | $146.8M | $124.8M | $107.6M | $105.2M | $89.7M | |||
| Accounts Receivable Net Current | $130.4M | $132.4M | $118.1M | $121.9M | $137.3M | $125.5M | $112.9M | $119.6M | $118.5M | $132.2M | $143.0M | $119.3M | $105.4M | $102.0M | $89.5M | |||
| Accounts Payable Current | $26.6M | $24.2M | $19.2M | $16.8M | $24.4M | $19.1M | $17.6M | $41.4M | $32.8M | $19.1M | $25.7M | $22.5M | $10.9M | $9.9M | $10.3M | |||
| Repayments Of Other Long Term Debt | $0.00 | $3.1M | $0.00 | $4.5M | $3.8M | |||||||||||||
| Minority Interest | $41.2M | $40.1M | $37.3M | $38.1M | $38.1M | $46.2M | $48.9M | $50.1M | $51.9M | $35.7M | $72.2M | $72.1M | $78.0M | $77.8M | $77.9M | |||
| Retained Earnings Accumulated Deficit | -$349.7M | -$352.8M | -$360.3M | -$354.9M | -$350.1M | -$326.1M | -$315.4M | -$308.1M | -$304.5M | -$133.4M | -$25.1M | -$17.9M | -$6.2M | -$5.2M | -$1.0M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.8M | -$774.0K | -$2.1M | $445.0K | -$17.0K | $325.0K | $397.0K | $655.0K | $413.0K | -$1.3M | -$764.0K | -$363.0K | $204.0K | $468.0K | $451.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Investing Cash Flow * | -$3.2M | $23.0M | $15.8M | -$116.4M | -$283.8M | -$20.5M | -$7.9M |
| Operating Cash Flow * | $74.7M | $38.8M | $15.3M | -$13.5M | $23.0M | $71.8M | $40.7M |
| Net Cash Provided By Used In Financing Activities | -$62.1M | -$54.6M | -$26.7M | $62.1M | $273.4M | -$29.6M | -$11.0M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $371.0K | -$2.6M | $629.0K | $521.0K | -$228.0K | $589.0K | -$104.0K |
| Share Based Compensation | $12.7M | $13.3M | $2.7M | $17.6M | $19.8M | $0.00 | $0.00 |
| Proceeds From Payments For Other Financing Activities | -$827.0K | -$758.0K | -$506.0K | -$15.0K | -$404.0K | $317.0K | -$448.0K |
| Proceeds From Long Term Lines Of Credit | $45.0M | $0.00 | $64.0M | $25.0M | $20.0M | $49.0M | $0.00 |
| Proceeds From Issuance Of Common Stock | $2.1M | $2.4M | $778.0K | $5.8M | $1.6M | $0.00 | $0.00 |
| Payments To Acquire Property Plant And Equipment | $2.6M | $1.0M | $7.4M | $1.5M | $13.5M | $16.6M | $2.3M |
| Increase Decrease In Inventories | -$8.6M | $16.4M | $6.0M | $18.6M | -$3.2M | $528.0K | $1.4M |
| Increase Decrease In Accounts Receivable | $916.0K | $10.7M | -$10.1M | $17.7M | $20.1M | $3.9M | $14.9M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$19.8M | $17.8M | -$5.3M | -$3.1M | $18.2M | $20.5M | $6.6M |
| Depreciation Depletion And Amortization | $47.0M | $49.6M | $57.4M | $55.4M | $34.9M | $28.6M | $30.3M |
| Increase Decrease In Other Operating Capital Net | $1.7M | $2.5M | $2.0M | -$9.7M | $16.5M | $733.0K | $3.9M |
| Proceeds From Payments For Acquisition Of Intangible Assets And Investments | $0.00 | -$709.0K | $0.00 | -$10.0M | -$7.4M | -$4.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Investing Cash Flow * | -$826.0K | -$1.0M | -$15.1M | -$4.7M | -$46.6M | -$451.0K |
| Operating Cash Flow * | -$19.3M | -$6.0M | $2.5M | -$21.0M | -$18.0M | $17.7M |
| Net Cash Provided By Used In Financing Activities | $947.0K | -$4.2M | $27.4M | $9.2M | $107.5M | $48.8M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $430.0K | -$544.0K | $461.0K | -$71.0K | -$221.0K | -$260.0K |
| Share Based Compensation | $2.4M | $3.0M | $1.8M | $4.9M | $1.9M | $0.00 |
| Proceeds From Payments For Other Financing Activities | -$203.0K | -$183.0K | -$36.0K | -$14.0K | -$4.0K | -$218.0K |
| Proceeds From Long Term Lines Of Credit | $15.0M | $0.00 | $49.0M | $15.0M | $0.00 | $49.0M |
| Proceeds From Issuance Of Common Stock | $150.0K | $177.0K | $84.0K | $2.1M | $16.0K | $0.00 |
| Payments To Acquire Property Plant And Equipment | $826.0K | $291.0K | $3.6M | $3.0M | $1.4M | $299.0K |
| Increase Decrease In Inventories | $1.9M | $4.1M | $5.3M | -$326.0K | $3.1M | $1.4M |
| Increase Decrease In Accounts Receivable | -$9.0M | $2.0M | -$13.2M | -$4.4M | -$2.6M | -$3.4M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$39.1M | -$7.3M | $2.3M | -$7.9M | -$14.1M | $3.8M |
| Depreciation Depletion And Amortization | $11.9M | $11.8M | $16.5M | $12.5M | $7.2M | $7.3M |
| Increase Decrease In Other Operating Capital Net | -$780.0K | $1.4M | $2.1M | $1.5M | ||
| Proceeds From Payments For Acquisition Of Intangible Assets And Investments | $0.00 | -$709.0K | $0.00 | -$1.5M | $513.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 66.6M | 64.5M | 62.6M | 61.4M | 45.5M |
| Weighted Average Number Of Diluted Shares Outstanding | 68.9M | 64.5M | 62.6M | 61.4M | 45.5M |
| Earnings Per Share Diluted | $0.33 | $-0.56 | $-2.49 | $-2.59 | $-0.15 |
| Earnings Per Share Basic | $0.34 | $-0.56 | $-2.49 | $-2.59 | $-0.15 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 66.9M | 66.5M | 66.0M | 65.3M | 64.1M | 63.4M | 62.8M | 62.6M | 62.1M | 61.7M | 61.5M | 60.5M | 41.8M | 41.8M | 41.8M |
| Weighted Average Number Of Diluted Shares Outstanding | 68.8M | 68.5M | 66.0M | 65.3M | 64.1M | 63.4M | 62.8M | 62.6M | 62.1M | 61.7M | 61.5M | 60.5M | 41.8M | 41.8M | 41.8M |
| Earnings Per Share Diluted | $0.05 | $0.11 | $-0.04 | $-0.08 | $-0.40 | $-0.08 | $-0.12 | $-0.06 | $-2.24 | $-1.76 | $-0.11 | $-0.19 | $-0.03 | $-0.10 | $-0.02 |
| Earnings Per Share Basic | $0.05 | $0.11 | $-0.04 | $-0.08 | $-0.40 | $-0.08 | $-0.12 | $-0.06 | $-2.24 | $-1.76 | $-0.11 | $-0.19 | $-0.03 | $-0.10 | $-0.02 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Depreciation And Amortization | $5.7M | $7.7M | $8.8M | $9.7M | $8.4M | $7.4M | $7.9M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $12.7M | $13.3M | $2.7M | $17.6M | -$39.0K | ||
| Provision For Doubtful Accounts | $1.3M | -$434.0K | -$1.1M | $5.2M | $485.0K | $1.2M | $2.2M |
| Capital Expenditures Incurred But Not Yet Paid | $240.0K | $42.0K | $1.3M | $419.0K | $695.0K | $336.0K | $34.0K |
| Stock Issued During Period Value New Issues | $2.1M | $2.4M | $778.0K | $5.8M | |||
| Additional Paid In Capital | $520.9M | $508.1M | $494.3M | $490.6M | $473.3M | ||
| Repayments Of Long Term Lines Of Credit | $45.0M | $15.0M | $49.0M | $25.0M | $20.0M | $49.0M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation And Amortization | $1.4M | $1.4M | $1.6M | $2.1M | $2.1M | $1.8M | $2.3M | $2.3M | $2.1M | $2.3M | $2.7M | $3.3M | $1.9M | $1.9M | $1.9M | $1.7M | $1.8M | $1.8M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.2M | $3.6M | $2.4M | $2.5M | $5.8M | $3.0M | $1.8M | -$2.7M | $1.8M | $4.6M | $4.6M | $4.9M | $5.9M | $5.9M | $2.0M | |||
| Provision For Doubtful Accounts | $650.0K | -$976.0K | -$1.3M | -$439.0K | $1.1M | $1.4M | $1.4M | $1.2M | $221.0K | -$550.0K | $191.0K | -$73.0K | $619.0K | $543.0K | ||||
| Capital Expenditures Incurred But Not Yet Paid | $140.0K | $218.0K | $0.00 | $76.0K | $157.0K | $21.0K | ||||||||||||
| Stock Issued During Period Value New Issues | $96.0K | $1.3M | $150.0K | $553.0K | $496.0K | $290.0K | $397.0K | $139.0K | $84.0K | $482.0K | $2.2M | $2.1M | $417.0K | $314.0K | $106.5M | |||
| Additional Paid In Capital | $517.5M | $514.8M | $510.4M | $503.1M | $501.0M | $497.0M | $492.5M | $490.6M | $492.5M | $478.0M | $473.8M | $467.9M | $158.5M | $146.2M | $142.9M | |||
| Repayments Of Long Term Lines Of Credit | $5.0M | $0.00 | $20.0M | $0.00 |
Most recent annual filing with the SEC: March 5, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.